Oncolytics Biotech Has Entered Into An Agreement With Leede Jones Gable As Underwriter And Book-runner To Purchase, On A Bought-deal Basis, 6,667,000 Units For Gross Proceeds Of $15M At $2.25/Unit
Oncolytics Biotech Has Entered Into An Agreement With Leede Jones Gable As Underwriter And Book-runner To Purchase, On A Bought-deal Basis, 6,667,000 Units For Gross Proceeds Of $15M At $2.25/Unit
Oncolytics Biotech 已与作为承销商和账簿管理人的 Leede Jones Gable 达成协议，以收购协议的方式购买666.7万套，总收益为1500万美元，每单位2.25美元
Oncolytics Biotech Has Entered Into An Agreement With Leede Jones Gable As Underwriter And Book-runner To Purchase, On A Bought-deal Basis, 6,667,000 Units For Gross Proceeds Of $15M At $2.25/Unit
Oncolytics Biotech 已与作为承销商和账簿管理人的 Leede Jones Gable 达成协议，以收购协议的方式购买666.7万套，总收益为1500万美元，每单位2.25美元